N6-Dimethylaminomethylidene-2'-deoxyisoguanosine manufacturers
|
| | N6-Dimethylaminomethylidene-2'-deoxyisoguanosine Basic information |
| Product Name: | N6-Dimethylaminomethylidene-2'-deoxyisoguanosine | | Synonyms: | N6-Dimethylaminomethylidene-2'-deoxyisoguanosine;2-DEOXY-N-[(DIMETHYLAMINO)METHYLIDENE]-1,2-DIHYDRO-2-OXO-ADENOSINE;Adenosine, 2'-deoxy-N-[(dimethylamino)methylene]-1,2-dihydro-2-oxo- (9CI);N6-Dimethylaminomethylidene-2’-deoxyisoguanosine | | CAS: | 146196-17-0 | | MF: | C13H18N6O4 | | MW: | 322.32 | | EINECS: | | | Product Categories: | | | Mol File: | 146196-17-0.mol |  |
| | N6-Dimethylaminomethylidene-2'-deoxyisoguanosine Chemical Properties |
| density | 1.66±0.1 g/cm3(Predicted) | | pka | 8.28±0.40(Predicted) |
| | N6-Dimethylaminomethylidene-2'-deoxyisoguanosine Usage And Synthesis |
| Uses | N6-Dimethylamino methylidene-2’-deoxyisoguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | N6-Dimethylaminomethylidene-2'-deoxyisoguanosine Preparation Products And Raw materials |
|